Sisu Pharma exploits cellular stress by directly targeting HSF1, the Master Regulator of the heat shock response. Our HSF1 targeting platform (HI-LiTe) is being developed to deliver selective HSF1 degraders for oncology and therapies for use in neurodegenerative conditions and infection, providing a unique approach to treating these devastating diseases.
Company Details
- Employees
- 2
- Founded
- -
- Address
- San Diego, California 92121, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- sisupharma.com
- Keywords
- London.
- HQ
- San Diego, California
Sisu Pharma Questions
Sisu Pharma's website is sisupharma.com
Sisu Pharma's LinkedIn profile is https://www.linkedin.com/company/sisu-pharma
Sisu Pharma has
2 employees.
View email and phone details for 2
employees at Sisu Pharma.
Sisu Pharma's industry is
Biotechnology Research
Sisu Pharma's top competitors are
Emerald Bioventures,
Phenovista,
Y Innovations,
Harmonia Healthcare,
Lsx - Partnering For Life Science Executives,
Adamed Laboratorios S.l.u.,
Cellective Biotherapy,
Ten63 Therapeutics,
Arc Medical Inc.,
Meliora Therapeutics.
Sisu Pharma's categories are Biotechnology Research
Sisu Pharma's founding year is 2019
